ArticlePharmaceutics2022

4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer's Disease.

Katarina Komatović et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.